Idiopathic Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Idiopathic Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial) [Phase 2]
A Phase 2 clinical trial evaluating ENV-101 for idiopathic pulmonary fibrosis and progressive fibrosing interstitial lung disease is listed …
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Atezolizumab for Idiopathic Pulmonary Fibrosis [Phase 1]
A Phase 1 clinical trial evaluating atezolizumab for idiopathic pulmonary fibrosis is ongoing but not currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
A Phase 2 trial evaluating Boehringer Ingelheim's BI 1819479 for improving lung function in idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]
A Phase 2 clinical study is evaluating SV001 for safety, tolerability, pharmacokinetics and immunogenicity in people with idiopathic pulmona…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Management of Progressive Disease in Idiopathic Pulmonary Fibrosis [Phase 4]
A Phase 4 clinical trial investigating management of progressive disease in idiopathic pulmonary fibrosis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease [Phase 2]
Phase 2 study evaluating the efficacy and safety of vixarelimab in idiopathic pulmonary fibrosis and systemic sclerosis-associated interstit…
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Inspiratory Effort Assessed Through Nasal Pressure Measurement in Patients With Idiopathic Pulmonary Fibrosis
A clinical trial evaluating inspiratory effort via nasal pressure measurement in patients with idiopathic pulmonary fibrosis is currently re…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis [Phase 1]
This clinical trial update describes a Phase 1 study evaluating autologous lung stem cell transplantation for idiopathic pulmonary fibrosis …
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Safety, Tolerability, and Efficacy of MN-001 (Tipelukast) in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 trial of MN-001 (tipelukast) in idiopathic pulmonary fibrosis has completed enrollment; results detailing safety, tolerability, and …
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis [Phase 2]
Phase 2 study of BI 1839100 for cough in idiopathic pulmonary fibrosis or progressive pulmonary fibrosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Genentech Xenon MRI Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 trial of Xenon MRI for idiopathic pulmonary fibrosis has posted results; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the Efficacy and Safety of HRS-9813 in Subjects With Pulmonary Fibrosis [Phase 2]
Phase II randomized, double-blind study evaluating HRS-9813 for idiopathic pulmonary fibrosis and progressive fibrosing interstitial lung di…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: A Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis [Phase 2]
A multicenter Phase 2 trial evaluating the efficacy, safety, and tolerability of HZN-825 in idiopathic pulmonary fibrosis has been terminate…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
A Phase 2 trial evaluating oral INS018_055 in idiopathic pulmonary fibrosis has completed, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Effect of Intrapulmonary Percussion Ventilation on Deposition of Inhaled Aerosols in Idiopathic Pulmonary Fibrosis [NA]
A completed clinical trial evaluated whether intrapulmonary percussion ventilation changes the deposition of inhaled aerosols in idiopathic …
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: This Study Tests Different Doses of BI 1015550 in Patients With Idiopathic Pulmonary Fibrosis (IPF). The Study Tests How BI 1015550 is Taken up by the Body and How Well it is Tolerated. [Phase 1]
This Phase 1 trial evaluates different doses of BI 1015550 in idiopathic pulmonary fibrosis, focusing on pharmacokinetics and tolerability.
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: A Multiple Ascending Doses (MAD) Study of PMG1015 in Idiopathic Pulmonary Fibrosis Subjects [Phase 1]
A Phase 1 MAD (multiple ascending dose) study of PMG1015 in idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 trial evaluating the efficacy and safety of Orvepitant for chronic cough in idiopathic pulmonary fibrosis; study completed and resul…
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF [Phase 2]
Phase 2 clinical trial update for the oral agent GRI-0621 in idiopathic pulmonary fibrosis reports biomarker modulation and inhibition of NK…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Study of ARO-MMP7 Inhalation Solution in Healthy Subjects and Patients With Idiopathic Pulmonary Fibrosis [Phase 1, Phase 2]
The document reports the completion of Phase 1 and Phase 2 trials of ARO-MMP7 Inhalation Solution in healthy subjects and patients with Idio…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis [Phase 2]
This document provides an update on a Phase 2 trial of TTI-101 in participants with idiopathic pulmonary fibrosis, indicating the study has …
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809) [Phase 2]
Imaging-based results from a Phase 2 study evaluating PLN-74809 in participants with idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Immunogenicity of HuL001 [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics, and immunogenicity of HuL001 in idiopathic pulmonary fibrosis has completed…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation Phase I Clinical Study to Assess the Safety, Pharmacokinetics, and Immunogenicity of HLX6018 in Healthy Subjects [Phase 1]
This document reports the completion of a Phase 1, randomized, double-blind, placebo-controlled, single-dose escalation study to assess the …
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPF [Phase 2]
A Phase 2 trial evaluating the efficacy of the investigational product(s) versus placebo in idiopathic pulmonary fibrosis was terminated; re…